![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Thompson Philip A. O'Brien Susan M. Wierda William G. Ferrajoli Alessandra Stingo Francesco Smith Susan C. Burger Jan A. Estrov Zeev Jain Nitin Kantarjian Hagop M. Keating Michael J.
Publisher: Blackwell Publishing
E-ISSN: 1097-0142|121|20|3612-3621
ISSN: 0008-543X
Source: Cancer, Vol.121, Iss.20, 2015-10, pp. : 3612-3621
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia
Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia
Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. :